Telegraaf
• 30 jul. 2025, 03:45 •
65%
Nieuw alzheimermedicijn biedt hoop in strijd tegen oprukkende volksziekte
Roche, the Swiss pharmaceutical company, is exploring the potential of an experimental drug called Trontinemab to slow down the progression of Alzheimer's disease, which they consider a significant advancement in combating the growing public health issue.